Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 3.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,787,904 shares of the company's stock after purchasing an additional 63,148 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.22% of Colgate-Palmolive worth $138,902,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the company. Sunpointe LLC grew its stake in shares of Colgate-Palmolive by 4.0% in the 4th quarter. Sunpointe LLC now owns 3,056 shares of the company's stock valued at $241,000 after buying an additional 117 shares during the period. Capital Advisors Inc. OK grew its stake in shares of Colgate-Palmolive by 1.4% in the 4th quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company's stock valued at $758,000 after buying an additional 129 shares during the period. Stratos Wealth Advisors LLC grew its stake in shares of Colgate-Palmolive by 4.5% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company's stock valued at $241,000 after buying an additional 130 shares during the period. Eads & Heald Wealth Management grew its stake in shares of Colgate-Palmolive by 0.6% in the 4th quarter. Eads & Heald Wealth Management now owns 20,744 shares of the company's stock valued at $1,639,000 after buying an additional 132 shares during the period. Finally, Chicago Partners Investment Group LLC grew its stake in shares of Colgate-Palmolive by 1.5% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 9,387 shares of the company's stock valued at $724,000 after buying an additional 136 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Colgate-Palmolive
In related news, COO Panagiotis Tsourapas sold 15,000 shares of the business's stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total value of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares in the company, valued at approximately $1,018,691.15. The trade was a 59.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider John Hazlin sold 20,989 shares of the business's stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the sale, the insider owned 17,645 shares in the company, valued at $1,663,041.25. This represents a 54.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 70,989 shares of company stock worth $6,756,713 in the last quarter. Company insiders own 0.43% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have commented on the company. TD Cowen restated a "hold" rating and issued a $85.00 target price on shares of Colgate-Palmolive in a research report on Tuesday, March 31st. Bank of America reduced their target price on Colgate-Palmolive from $105.00 to $102.00 and set a "buy" rating on the stock in a research report on Friday, April 10th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Sunday, March 29th. The Goldman Sachs Group restated a "buy" rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $99.00 target price on shares of Colgate-Palmolive in a research report on Monday. Twelve investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of "Moderate Buy" and a consensus target price of $95.88.
View Our Latest Report on CL
Colgate-Palmolive Price Performance
CL stock opened at $88.21 on Thursday. The company has a current ratio of 1.02, a quick ratio of 0.29 and a debt-to-equity ratio of 16.33. The company has a market capitalization of $70.77 billion, a PE ratio of 34.32, a P/E/G ratio of 4.47 and a beta of 0.31. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The business's fifty day moving average price is $87.60 and its 200 day moving average price is $84.28.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 EPS. On average, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.83 EPS for the current year.
Colgate-Palmolive Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.4%. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.52. Colgate-Palmolive's dividend payout ratio (DPR) is presently 82.49%.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
